Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF trial (Q37394083)
Jump to navigation
Jump to search
scientific article published on 10 June 2016
Language | Label | Description | Also known as |
---|---|---|---|
English | Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF trial |
scientific article published on 10 June 2016 |
Statements
1 reference
Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF trial (English)
1 reference
John R Teerlink
Orly Vardeny
Brian Claggett
Milton Packer
Akshay S Desai
Martin Lefkowitz
Victor Shi
Scott D Solomon
Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) Investigators
10 June 2016
1 reference
1 reference